Personalis Analyst Price Targets - Benzinga

Personalis Inc

PSNLNASDAQ

Trade with Public

Trade with Public

$16.22

0.050.31%

Dern. MÀJ: Oct 2, 12:05 PM

$16.46

0.291.79%

Aperçu Actualités Prévisions de résultats ÉvénementsObjectifs de coursDonnées financières Sentiment Actionnariat Comparer Options Rapport sur les stocks

Personalis Analyst Price Targets - Benzinga

Personalis Analyst Price Targets

Wall Street analyst price targets and consensus rating for Personalis (PSNL).

Price Target Range — 12 Quarters

Analyst Consensus — 6 Analysts

4Buy

2Hold

Consensus RatingBuy# Analysts6Avg. Consensus PT$13Upside to Avg. PT-18.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 20, 2026	Lake Street	Thomas Flaten	Downgrade	Buy→Hold	$16
Jul 20, 2026	BTIG	Mark Massaro	PT Raise	Buy	$11→$16
Jul 20, 2026	Needham	Mike Matson	Downgrade	Buy→Hold	—
Jul 17, 2026	Needham	Mike Matson	PT Raise	Buy	$12→$17
Jul 9, 2026	Morgan Stanley	Tejas Savant	PT Raise	Equal-Weight	$9→$13
May 12, 2026	Morgan Stanley	Tejas Savant	PT Cut	Equal-Weight	$10→$9
May 11, 2026	BTIG	Mark Massaro	PT Cut	Buy	$13→$11
Mar 5, 2026	Morgan Stanley	Tejas Savant	PT Cut	Equal-Weight	$11→$10
Feb 27, 2026	Needham	Mike Matson	PT Raise	Buy	$10→$12
Feb 11, 2026	BTIG	Mark Massaro	PT Raise	Buy	$12→$13
Jan 26, 2026	Guggenheim	Subbu Nambi	PT Raise	Buy	$12→$13
Jan 9, 2026	BTIG	Mark Massaro	Maintained	Buy	$12
Dec 2, 2025	Morgan Stanley	Tejas Savant	PT Raise	Equal-Weight	$9→$11
Nov 11, 2025	Morgan Stanley	Tejas Savant	PT Raise	Equal-Weight	$5→$9
Nov 11, 2025	Guggenheim	Subbu Nambi	PT Raise	Buy	$6→$12
Nov 11, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	PT Raise	Buy	$10→$13
Nov 11, 2025	BTIG	Mark Massaro	PT Raise	Buy	$11→$12
Nov 6, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	PT Raise	Buy	$9→$10
Nov 5, 2025	Needham	Mike Matson	PT Raise	Buy	$7→$10
Oct 22, 2025	BTIG	Mark Massaro	PT Raise	Buy	$6→$11

More with Benzinga EdgeGet Access

Analyst Ratings News

Tempus AI Makes Billion-Dollar Bet on the Future of Cancer Monitoring

Tempus AI acquires Personalis for $1.5B to target the $20B MRD cancer monitoring market. Get full deal details and analysis.

Vandana Singh

PRO
Lake Street Downgrades Personalis to Hold, Announces $16.25 Price Target

Lake Street analyst Thomas Flaten downgrades Personalis (NASDAQ:PSNL) from Buy to Hold and announces $16.25 price target.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on Personalis, Raises Price Target to $16.25

BTIG analyst Mark Massaro maintains Personalis (NASDAQ:PSNL) with a Buy and raises the price target from $11 to $16.25.

Benzinga Newsdesk

PRO
Needham Downgrades Personalis to Hold

Needham analyst Mike Matson downgrades Personalis (NASDAQ:PSNL) from Buy to Hold.

Benzinga Newsdesk

PRO
Needham Maintains Buy on Personalis, Raises Price Target to $17

Needham analyst Mike Matson maintains Personalis (NASDAQ:PSNL) with a Buy and raises the price target from $12 to $17.

Benzinga Newsdesk

PRO
Morgan Stanley Maintains Equal-Weight on Personalis, Raises Price Target to $13

Morgan Stanley analyst Tejas Savant maintains Personalis (NASDAQ:PSNL) with a Equal-Weight and raises the price target from $9 to $13.

Benzinga Newsdesk